{"favorite_id": 10094, "calc_type": "calculator", "dosing": false, "full_title_en": "GALAD Model for Hepatocellular Carcinoma (HCC)", "short_title_en": "GALAD Model for HCC", "medium_description_en": "Diagnoses HCC based on serum biomarkers in patients with chronic liver disease (CLD).", "short_description_en": "HCC diagnosis.", "before_use": "", "instructions_en": "", "purpose_en": ["Diagnosis", "Calculation"], "disease_en": ["Hepatocellular Carcinoma"], "specialty_en": ["Hepatology", "Internal Medicine", "Hospitalist Medicine", "Hematology and Oncology"], "chief_complaint_en": ["Jaundice", "Abdominal Pain", "Weight Loss/Gain"], "system_en": ["Oncologic", "Gastrointestinal"], "search_abbreviation_en": ["Chronic liver disease", "CLD", "GALAD score", "HCC diagnosis"], "slug": "galad-model-hepatocellular-carcinoma-hcc", "seo": {"meta_description_en": "The GALAD Model for Hepatocellular Carcinoma (HCC) diagnoses HCC based on serum biomarkers.", "keywords_en": "Chronic liver disease, CLD, GALAD score, HCC diagnosis"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-15b8d3d8-7fff-467a-afd0-8d30007c313b\">Use in patients with chronic liver disease (CLD).</span></p>", "pearls_pitfalls_en": "", "why_use_en": "<ul>\n<li dir=\"ltr\">Estimates risk that a CLD patient has HCC using only tumor markers and demographics (i.e., no imaging).</li>\n<li dir=\"ltr\"><abbr title=\"Area under receiver operating characteristic curve\">AUROC</abbr> was 0.92 in one validation study (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27936479\" target=\"_blank\">Best 2016</a>).</li>\n</ul>"}, "next_steps": {"advice_en": "<p><span id=\"docs-internal-guid-78890880-7fff-e30a-af6a-112a6a74fb6e\">Use clinical judgment to determine how closely to surveil patients for HCC.</span></p>", "management_en": "<p><span id=\"docs-internal-guid-08c47fcc-7fff-3098-e3d6-27b8725ec8bc\">No guidelines currently exist for thresholds at which to image patients based on GALAD results. One large prospective study suggests patients with AFP &ge;10 ng/mL or AFP-L3 &ge;5% be imaged with CT or MRI every 3-6 months (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21132575\" target=\"_blank\">Kumada 2011</a>).</span></p>", "critical_actions_en": ""}, "about": {"formula_en": "<p dir=\"ltr\">GALAD Score = -10.08 + 0.09 x A + 1.67 x G + 2.34 log<sub>10</sub>(AF) + 0.04 x L + 1.33 x log<sub>10</sub>(D)</p>\n<p dir=\"ltr\">Where variables are as follows:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"72\" /><col width=\"226\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Variable</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Value</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>G</strong>ender</p>\n</td>\n<td>\n<p dir=\"ltr\">0 if female</p>\n<p dir=\"ltr\">1 if male</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>A</strong>ge</p>\n</td>\n<td>\n<p dir=\"ltr\">Age, years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">AFP-<strong>L</strong>3</p>\n</td>\n<td>\n<p dir=\"ltr\">Alpha fetoprotein L3, %</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>AF</strong>P</p>\n</td>\n<td>\n<p dir=\"ltr\">Alpha fetoprotein, ng/mL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>D</strong>CP</p>\n</td>\n<td>\n<p dir=\"ltr\">Des-carboxy-prothrombin, ng/mL</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p></p>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<p dir=\"ltr\">Probability of concurrent HCC in this CLD patient = exp(Z) / (1 + exp(Z))</p>\n<p dir=\"ltr\">Where Z = GALAD Score</p>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/24220911", "text": "Johnson PJ, Pirrie SJ, Cox TF, et al. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. Cancer Epidemiol Biomarkers Prev. 2014;23(1):144-53."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/21132575", "text": "Kumada T, Toyoda H, Kiriyama S, et al. Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus. J Gastroenterol. 2011;46(4):536-44."}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/27936479", "text": "Best J, Bilgi H, Heider D, et al. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Z Gastroenterol. 2016;54(12):1296-1305."}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Philip J. Johnson", "creator_info": {"about_en": "Philip J. Johnson, MD, FRCP, is a professor in translational oncology at the University of Liverpool. He is also the deputy director of the North West Cancer Research Centre, University of Liverpool. Dr. Johnson\u2019s primary research is focused on diagnosis and prognosis of hepatobiliary and pancreatic cancer.", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-philip-j-johnson.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Johnson+PJ%5Bau%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "toggle", "label_en": "Gender", "name": "gender", "options": [{"label": "Female", "value": 0}, {"label": "Male", "value": 1}], "conditionality": "", "show_points": false, "optional": false}, {"type": "textbox", "label_en": "Age", "name": "age", "unit": "age", "conditionality": "", "optional": false, "unit_info": {"name": "Age", "conversion": 1, "error_min": 0.001, "error_max": 120, "warn_min": 0.1, "warn_max": 100, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "years", "units_us": "years"}}, {"type": "textbox", "label_en": "Alpha fetoprotein L3 (AFP-L3)", "name": "afpl3", "unit": "afp_l3", "conditionality": "", "optional": false, "unit_info": {"name": "AFP_L3", "conversion": 1, "error_min": 0, "error_max": 100, "warn_min": 0, "warn_max": 10, "normal_max_si": 10, "normal_min_si": 0, "normal_min_us": 0, "units_si": "%", "units_us": "%", "normal_max_us": 10}}, {"type": "textbox", "label_en": "Alpha fetoprotein (AFP)", "name": "afp", "unit": "afp", "conditionality": "", "optional": false, "unit_info": {"name": "AFP", "conversion": 1, "error_min": 0, "error_max": 100000, "warn_min": 0, "warn_max": 6, "normal_max_si": 6, "normal_min_si": 0, "normal_min_us": 0, "units_si": "ng/mL", "units_us": "ng/mL", "normal_max_us": 6}}, {"type": "textbox", "label_en": "Des-carboxy-prothrombin (DCP)", "name": "dcp", "unit": "dcp", "conditionality": "", "optional": false, "unit_info": {"name": "DCP", "conversion": 1, "error_min": 0, "error_max": 100, "warn_min": 0, "warn_max": 7.5, "normal_max_si": 7.5, "normal_min_si": 0, "normal_min_us": 0, "units_si": "ng/mL", "units_us": "ng/mL", "normal_max_us": 7.5}}], "md5": "06ddcaa914cedcc65bf25bddf70ada75", "related_calcs": [{"calcId": 10147, "short_title_en": "UKELD Score", "slug": "united-kingdom-model-end-stage-liver-disease-ukeld"}, {"calcId": 10240, "short_title_en": "CLIF-C ACLF", "slug": "clif-c-aclf-acute-chronic-liver-failure"}, {"calcId": 3112, "short_title_en": "Simplified AIH Score", "slug": "simplified-autoimmune-hepatitis-aih-score"}]}